video

sound

Persian Version

View:

96,588

Download:

59,481

Cites:

Information Journal Paper

Title

SUCCESSFUL TREATMENT OF CHRONIC MYELOGENIC LEUKEMIA (CML) WITH IMATINIB AFTER RENAL TRANSPLANTATION

Pages

  388-390

Abstract

 CHRONIC MYELOGENIC LEUKEMIA (CML) is a rare malignant disorder after solid organ transplantation, especially in RENAL TRANSPLANT recipients. IMATINIB Mesylate is currently approved as first line treatment of CML. Most reports on CML are from kidney recipients who received azathioprine in combination with cyclosporine and prednisolone as immunosuppressive therapy. We report a case with CML who was treated with Mycophenolate Mofetil.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    EISHEI OSKUEI, ALI, MAKHDOOMI, KHADIJEH, ABKHIZ, SAEED, VOSSOGHIAN, SARA, & FARROKHPOUR, MOHSEN. (2014). SUCCESSFUL TREATMENT OF CHRONIC MYELOGENIC LEUKEMIA (CML) WITH IMATINIB AFTER RENAL TRANSPLANTATION. ARCHIVES OF IRANIAN MEDICINE, 17(5), 388-390. SID. https://sid.ir/paper/280927/en

    Vancouver: Copy

    EISHEI OSKUEI ALI, MAKHDOOMI KHADIJEH, ABKHIZ SAEED, VOSSOGHIAN SARA, FARROKHPOUR MOHSEN. SUCCESSFUL TREATMENT OF CHRONIC MYELOGENIC LEUKEMIA (CML) WITH IMATINIB AFTER RENAL TRANSPLANTATION. ARCHIVES OF IRANIAN MEDICINE[Internet]. 2014;17(5):388-390. Available from: https://sid.ir/paper/280927/en

    IEEE: Copy

    ALI EISHEI OSKUEI, KHADIJEH MAKHDOOMI, SAEED ABKHIZ, SARA VOSSOGHIAN, and MOHSEN FARROKHPOUR, “SUCCESSFUL TREATMENT OF CHRONIC MYELOGENIC LEUKEMIA (CML) WITH IMATINIB AFTER RENAL TRANSPLANTATION,” ARCHIVES OF IRANIAN MEDICINE, vol. 17, no. 5, pp. 388–390, 2014, [Online]. Available: https://sid.ir/paper/280927/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops